nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—CYP2D6—breast cancer	0.13	0.538	CbGaD
Ropinirole—CYP3A4—breast cancer	0.112	0.462	CbGaD
Ropinirole—HTR2B—Raloxifene—breast cancer	0.0699	0.188	CbGbCtD
Ropinirole—CYP1A2—Anastrozole—breast cancer	0.0327	0.0882	CbGbCtD
Ropinirole—CYP1A2—Toremifene—breast cancer	0.03	0.0806	CbGbCtD
Ropinirole—CYP3A4—Exemestane—breast cancer	0.0226	0.061	CbGbCtD
Ropinirole—CYP2D6—Idarubicin—breast cancer	0.0204	0.0551	CbGbCtD
Ropinirole—CYP3A4—Letrozole—breast cancer	0.0193	0.0518	CbGbCtD
Ropinirole—CYP3A4—Anastrozole—breast cancer	0.0172	0.0462	CbGbCtD
Ropinirole—CYP3A4—Toremifene—breast cancer	0.0157	0.0423	CbGbCtD
Ropinirole—CYP3A4—Fulvestrant—breast cancer	0.0146	0.0393	CbGbCtD
Ropinirole—CYP3A4—Thiotepa—breast cancer	0.013	0.035	CbGbCtD
Ropinirole—CYP3A4—Ixabepilone—breast cancer	0.0119	0.032	CbGbCtD
Ropinirole—CYP3A4—Lapatinib—breast cancer	0.0114	0.0308	CbGbCtD
Ropinirole—CYP1A2—Tamoxifen—breast cancer	0.0109	0.0295	CbGbCtD
Ropinirole—CYP2D6—Vinorelbine—breast cancer	0.00999	0.0269	CbGbCtD
Ropinirole—CYP2D6—Tamoxifen—breast cancer	0.00901	0.0243	CbGbCtD
Ropinirole—CYP3A4—Raloxifene—breast cancer	0.00868	0.0234	CbGbCtD
Ropinirole—CYP1A2—Fluorouracil—breast cancer	0.00806	0.0217	CbGbCtD
Ropinirole—CYP3A4—Vinorelbine—breast cancer	0.00635	0.0171	CbGbCtD
Ropinirole—CYP2D6—Vinblastine—breast cancer	0.00615	0.0166	CbGbCtD
Ropinirole—CYP3A4—Tamoxifen—breast cancer	0.00573	0.0154	CbGbCtD
Ropinirole—CYP3A4—Mitoxantrone—breast cancer	0.00559	0.0151	CbGbCtD
Ropinirole—CYP3A4—Paclitaxel—breast cancer	0.00446	0.012	CbGbCtD
Ropinirole—CYP3A4—Irinotecan—breast cancer	0.0044	0.0119	CbGbCtD
Ropinirole—CYP3A4—Vinblastine—breast cancer	0.00391	0.0105	CbGbCtD
Ropinirole—CYP2D6—Doxorubicin—breast cancer	0.00378	0.0102	CbGbCtD
Ropinirole—CYP3A4—Docetaxel—breast cancer	0.00323	0.00868	CbGbCtD
Ropinirole—CYP3A4—Doxorubicin—breast cancer	0.0024	0.00647	CbGbCtD
Ropinirole—DRD5—female reproductive system—breast cancer	0.00026	0.0434	CbGeAlD
Ropinirole—DRD5—female gonad—breast cancer	0.000236	0.0395	CbGeAlD
Ropinirole—ADRA2C—nipple—breast cancer	0.000228	0.0381	CbGeAlD
Ropinirole—DRD5—endocrine gland—breast cancer	0.00022	0.0367	CbGeAlD
Ropinirole—CYP1A2—nipple—breast cancer	0.000198	0.033	CbGeAlD
Ropinirole—HTR2B—skin of body—breast cancer	0.000185	0.031	CbGeAlD
Ropinirole—ADRA2A—nipple—breast cancer	0.000182	0.0304	CbGeAlD
Ropinirole—HTR2B—endometrium—breast cancer	0.000175	0.0292	CbGeAlD
Ropinirole—HTR2B—uterus—breast cancer	0.000161	0.0269	CbGeAlD
Ropinirole—HTR1B—female reproductive system—breast cancer	0.000161	0.0269	CbGeAlD
Ropinirole—HTR2B—adipose tissue—breast cancer	0.000158	0.0263	CbGeAlD
Ropinirole—HTR1D—female reproductive system—breast cancer	0.000156	0.026	CbGeAlD
Ropinirole—HTR2C—female reproductive system—breast cancer	0.000154	0.0258	CbGeAlD
Ropinirole—HTR2B—female reproductive system—breast cancer	0.000145	0.0242	CbGeAlD
Ropinirole—HTR2B—adrenal gland—breast cancer	0.000141	0.0236	CbGeAlD
Ropinirole—ADRA2C—endometrium—breast cancer	0.000138	0.023	CbGeAlD
Ropinirole—HTR1B—endocrine gland—breast cancer	0.000136	0.0227	CbGeAlD
Ropinirole—DRD2—pituitary gland—breast cancer	0.000128	0.0214	CbGeAlD
Ropinirole—HTR2A—embryo—breast cancer	0.000128	0.0213	CbGeAlD
Ropinirole—ADRA2C—uterus—breast cancer	0.000127	0.0212	CbGeAlD
Ropinirole—HTR1A—adrenal gland—breast cancer	0.000127	0.0212	CbGeAlD
Ropinirole—ADRA2C—pituitary gland—breast cancer	0.000125	0.0208	CbGeAlD
Ropinirole—ADRA2C—adipose tissue—breast cancer	0.000124	0.0207	CbGeAlD
Ropinirole—ADRA2C—adrenal gland—breast cancer	0.000111	0.0186	CbGeAlD
Ropinirole—HTR1A—endocrine gland—breast cancer	0.00011	0.0183	CbGeAlD
Ropinirole—ADRA2A—endometrium—breast cancer	0.00011	0.0183	CbGeAlD
Ropinirole—HTR2A—epithelium—breast cancer	0.000104	0.0174	CbGeAlD
Ropinirole—ADRA2C—female gonad—breast cancer	0.000104	0.0173	CbGeAlD
Ropinirole—ADRA2A—uterus—breast cancer	0.000101	0.0169	CbGeAlD
Ropinirole—ADRA2A—pituitary gland—breast cancer	9.94e-05	0.0166	CbGeAlD
Ropinirole—DRD2—endocrine gland—breast cancer	9.93e-05	0.0166	CbGeAlD
Ropinirole—ADRA2A—adipose tissue—breast cancer	9.9e-05	0.0165	CbGeAlD
Ropinirole—ADRA2A—female reproductive system—breast cancer	9.1e-05	0.0152	CbGeAlD
Ropinirole—ADRA2A—adrenal gland—breast cancer	8.88e-05	0.0148	CbGeAlD
Ropinirole—HTR2B—lymph node—breast cancer	8.47e-05	0.0142	CbGeAlD
Ropinirole—HTR2A—pituitary gland—breast cancer	8.45e-05	0.0141	CbGeAlD
Ropinirole—CYP1A2—endocrine gland—breast cancer	8.37e-05	0.014	CbGeAlD
Ropinirole—ADRA2A—female gonad—breast cancer	8.28e-05	0.0138	CbGeAlD
Ropinirole—HTR2A—female reproductive system—breast cancer	7.74e-05	0.0129	CbGeAlD
Ropinirole—ADRA2A—endocrine gland—breast cancer	7.7e-05	0.0129	CbGeAlD
Ropinirole—HTR2A—adrenal gland—breast cancer	7.55e-05	0.0126	CbGeAlD
Ropinirole—CYP3A4—female reproductive system—breast cancer	7.16e-05	0.012	CbGeAlD
Ropinirole—CYP2D6—female reproductive system—breast cancer	7.05e-05	0.0118	CbGeAlD
Ropinirole—ADRA2C—lymph node—breast cancer	6.67e-05	0.0111	CbGeAlD
Ropinirole—HTR2A—endocrine gland—breast cancer	6.55e-05	0.0109	CbGeAlD
Ropinirole—CYP2D6—female gonad—breast cancer	6.41e-05	0.0107	CbGeAlD
Ropinirole—CYP3A4—endocrine gland—breast cancer	6.06e-05	0.0101	CbGeAlD
Ropinirole—CYP2D6—endocrine gland—breast cancer	5.96e-05	0.00996	CbGeAlD
Ropinirole—ADRA2A—lymph node—breast cancer	5.32e-05	0.00889	CbGeAlD
Ropinirole—Dysgeusia—Methotrexate—breast cancer	1.91e-05	6.85e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Docetaxel—breast cancer	1.9e-05	6.84e-05	CcSEcCtD
Ropinirole—Connective tissue disorder—Doxorubicin—breast cancer	1.9e-05	6.84e-05	CcSEcCtD
Ropinirole—Dyspnoea—Capecitabine—breast cancer	1.9e-05	6.84e-05	CcSEcCtD
Ropinirole—Fatigue—Docetaxel—breast cancer	1.9e-05	6.83e-05	CcSEcCtD
Ropinirole—Angiopathy—Epirubicin—breast cancer	1.9e-05	6.83e-05	CcSEcCtD
Ropinirole—Urethral disorder—Doxorubicin—breast cancer	1.9e-05	6.82e-05	CcSEcCtD
Ropinirole—Nausea—Irinotecan—breast cancer	1.89e-05	6.81e-05	CcSEcCtD
Ropinirole—Nausea—Mitoxantrone—breast cancer	1.89e-05	6.81e-05	CcSEcCtD
Ropinirole—Immune system disorder—Epirubicin—breast cancer	1.89e-05	6.8e-05	CcSEcCtD
Ropinirole—Mediastinal disorder—Epirubicin—breast cancer	1.88e-05	6.78e-05	CcSEcCtD
Ropinirole—Pain—Docetaxel—breast cancer	1.88e-05	6.78e-05	CcSEcCtD
Ropinirole—Constipation—Docetaxel—breast cancer	1.88e-05	6.78e-05	CcSEcCtD
Ropinirole—Back pain—Methotrexate—breast cancer	1.88e-05	6.77e-05	CcSEcCtD
Ropinirole—Dyspepsia—Capecitabine—breast cancer	1.88e-05	6.75e-05	CcSEcCtD
Ropinirole—Chills—Epirubicin—breast cancer	1.88e-05	6.75e-05	CcSEcCtD
Ropinirole—Arrhythmia—Epirubicin—breast cancer	1.87e-05	6.72e-05	CcSEcCtD
Ropinirole—Visual impairment—Doxorubicin—breast cancer	1.86e-05	6.71e-05	CcSEcCtD
Ropinirole—Asthenia—Paclitaxel—breast cancer	1.86e-05	6.71e-05	CcSEcCtD
Ropinirole—Decreased appetite—Capecitabine—breast cancer	1.85e-05	6.67e-05	CcSEcCtD
Ropinirole—Alopecia—Epirubicin—breast cancer	1.85e-05	6.65e-05	CcSEcCtD
Ropinirole—Nausea—Gemcitabine—breast cancer	1.84e-05	6.63e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Capecitabine—breast cancer	1.84e-05	6.62e-05	CcSEcCtD
Ropinirole—Fatigue—Capecitabine—breast cancer	1.84e-05	6.62e-05	CcSEcCtD
Ropinirole—Pruritus—Paclitaxel—breast cancer	1.84e-05	6.61e-05	CcSEcCtD
Ropinirole—Vision blurred—Methotrexate—breast cancer	1.83e-05	6.6e-05	CcSEcCtD
Ropinirole—Mental disorder—Epirubicin—breast cancer	1.83e-05	6.59e-05	CcSEcCtD
Ropinirole—Pain—Capecitabine—breast cancer	1.82e-05	6.56e-05	CcSEcCtD
Ropinirole—Constipation—Capecitabine—breast cancer	1.82e-05	6.56e-05	CcSEcCtD
Ropinirole—Malnutrition—Epirubicin—breast cancer	1.82e-05	6.55e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Docetaxel—breast cancer	1.82e-05	6.53e-05	CcSEcCtD
Ropinirole—Nausea—Fluorouracil—breast cancer	1.81e-05	6.52e-05	CcSEcCtD
Ropinirole—Eye disorder—Doxorubicin—breast cancer	1.81e-05	6.51e-05	CcSEcCtD
Ropinirole—Ill-defined disorder—Methotrexate—breast cancer	1.8e-05	6.49e-05	CcSEcCtD
Ropinirole—Tinnitus—Doxorubicin—breast cancer	1.8e-05	6.49e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Docetaxel—breast cancer	1.8e-05	6.48e-05	CcSEcCtD
Ropinirole—Anaemia—Methotrexate—breast cancer	1.8e-05	6.47e-05	CcSEcCtD
Ropinirole—Flushing—Doxorubicin—breast cancer	1.8e-05	6.46e-05	CcSEcCtD
Ropinirole—Cardiac disorder—Doxorubicin—breast cancer	1.8e-05	6.46e-05	CcSEcCtD
Ropinirole—Flatulence—Epirubicin—breast cancer	1.79e-05	6.45e-05	CcSEcCtD
Ropinirole—Tension—Epirubicin—breast cancer	1.79e-05	6.43e-05	CcSEcCtD
Ropinirole—Dysgeusia—Epirubicin—breast cancer	1.78e-05	6.41e-05	CcSEcCtD
Ropinirole—Diarrhoea—Paclitaxel—breast cancer	1.78e-05	6.4e-05	CcSEcCtD
Ropinirole—Nervousness—Epirubicin—breast cancer	1.77e-05	6.36e-05	CcSEcCtD
Ropinirole—Back pain—Epirubicin—breast cancer	1.76e-05	6.34e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Capecitabine—breast cancer	1.76e-05	6.32e-05	CcSEcCtD
Ropinirole—Angiopathy—Doxorubicin—breast cancer	1.76e-05	6.32e-05	CcSEcCtD
Ropinirole—Malaise—Methotrexate—breast cancer	1.75e-05	6.31e-05	CcSEcCtD
Ropinirole—Muscle spasms—Epirubicin—breast cancer	1.75e-05	6.3e-05	CcSEcCtD
Ropinirole—Immune system disorder—Doxorubicin—breast cancer	1.75e-05	6.29e-05	CcSEcCtD
Ropinirole—Vertigo—Methotrexate—breast cancer	1.75e-05	6.29e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Capecitabine—breast cancer	1.74e-05	6.27e-05	CcSEcCtD
Ropinirole—Mediastinal disorder—Doxorubicin—breast cancer	1.74e-05	6.27e-05	CcSEcCtD
Ropinirole—Abdominal pain—Docetaxel—breast cancer	1.74e-05	6.26e-05	CcSEcCtD
Ropinirole—Body temperature increased—Docetaxel—breast cancer	1.74e-05	6.26e-05	CcSEcCtD
Ropinirole—Leukopenia—Methotrexate—breast cancer	1.74e-05	6.26e-05	CcSEcCtD
Ropinirole—Chills—Doxorubicin—breast cancer	1.74e-05	6.25e-05	CcSEcCtD
Ropinirole—Arrhythmia—Doxorubicin—breast cancer	1.73e-05	6.22e-05	CcSEcCtD
Ropinirole—Dizziness—Paclitaxel—breast cancer	1.72e-05	6.18e-05	CcSEcCtD
Ropinirole—Vision blurred—Epirubicin—breast cancer	1.72e-05	6.17e-05	CcSEcCtD
Ropinirole—Alopecia—Doxorubicin—breast cancer	1.71e-05	6.15e-05	CcSEcCtD
Ropinirole—Cough—Methotrexate—breast cancer	1.7e-05	6.11e-05	CcSEcCtD
Ropinirole—Mental disorder—Doxorubicin—breast cancer	1.7e-05	6.1e-05	CcSEcCtD
Ropinirole—Urticaria—Capecitabine—breast cancer	1.69e-05	6.1e-05	CcSEcCtD
Ropinirole—Ill-defined disorder—Epirubicin—breast cancer	1.69e-05	6.08e-05	CcSEcCtD
Ropinirole—Body temperature increased—Capecitabine—breast cancer	1.69e-05	6.07e-05	CcSEcCtD
Ropinirole—Abdominal pain—Capecitabine—breast cancer	1.69e-05	6.07e-05	CcSEcCtD
Ropinirole—Convulsion—Methotrexate—breast cancer	1.69e-05	6.06e-05	CcSEcCtD
Ropinirole—Malnutrition—Doxorubicin—breast cancer	1.68e-05	6.06e-05	CcSEcCtD
Ropinirole—Anaemia—Epirubicin—breast cancer	1.68e-05	6.05e-05	CcSEcCtD
Ropinirole—Agitation—Epirubicin—breast cancer	1.67e-05	6.02e-05	CcSEcCtD
Ropinirole—Flatulence—Doxorubicin—breast cancer	1.66e-05	5.97e-05	CcSEcCtD
Ropinirole—Chest pain—Methotrexate—breast cancer	1.66e-05	5.96e-05	CcSEcCtD
Ropinirole—Arthralgia—Methotrexate—breast cancer	1.66e-05	5.96e-05	CcSEcCtD
Ropinirole—Myalgia—Methotrexate—breast cancer	1.66e-05	5.96e-05	CcSEcCtD
Ropinirole—Tension—Doxorubicin—breast cancer	1.65e-05	5.95e-05	CcSEcCtD
Ropinirole—Vomiting—Paclitaxel—breast cancer	1.65e-05	5.94e-05	CcSEcCtD
Ropinirole—Dysgeusia—Doxorubicin—breast cancer	1.65e-05	5.93e-05	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.64e-05	5.92e-05	CcSEcCtD
Ropinirole—Malaise—Epirubicin—breast cancer	1.64e-05	5.91e-05	CcSEcCtD
Ropinirole—Rash—Paclitaxel—breast cancer	1.64e-05	5.9e-05	CcSEcCtD
Ropinirole—Dermatitis—Paclitaxel—breast cancer	1.64e-05	5.89e-05	CcSEcCtD
Ropinirole—Discomfort—Methotrexate—breast cancer	1.64e-05	5.89e-05	CcSEcCtD
Ropinirole—Nervousness—Doxorubicin—breast cancer	1.64e-05	5.89e-05	CcSEcCtD
Ropinirole—Vertigo—Epirubicin—breast cancer	1.64e-05	5.88e-05	CcSEcCtD
Ropinirole—Syncope—Epirubicin—breast cancer	1.63e-05	5.87e-05	CcSEcCtD
Ropinirole—Leukopenia—Epirubicin—breast cancer	1.63e-05	5.86e-05	CcSEcCtD
Ropinirole—Back pain—Doxorubicin—breast cancer	1.63e-05	5.86e-05	CcSEcCtD
Ropinirole—Headache—Paclitaxel—breast cancer	1.63e-05	5.86e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Docetaxel—breast cancer	1.62e-05	5.84e-05	CcSEcCtD
Ropinirole—Muscle spasms—Doxorubicin—breast cancer	1.62e-05	5.83e-05	CcSEcCtD
Ropinirole—Palpitations—Epirubicin—breast cancer	1.61e-05	5.79e-05	CcSEcCtD
Ropinirole—Confusional state—Methotrexate—breast cancer	1.6e-05	5.76e-05	CcSEcCtD
Ropinirole—Loss of consciousness—Epirubicin—breast cancer	1.6e-05	5.76e-05	CcSEcCtD
Ropinirole—Cough—Epirubicin—breast cancer	1.59e-05	5.72e-05	CcSEcCtD
Ropinirole—Vision blurred—Doxorubicin—breast cancer	1.59e-05	5.71e-05	CcSEcCtD
Ropinirole—Asthenia—Docetaxel—breast cancer	1.58e-05	5.69e-05	CcSEcCtD
Ropinirole—Convulsion—Epirubicin—breast cancer	1.58e-05	5.67e-05	CcSEcCtD
Ropinirole—Infection—Methotrexate—breast cancer	1.58e-05	5.67e-05	CcSEcCtD
Ropinirole—Hypertension—Epirubicin—breast cancer	1.57e-05	5.65e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Capecitabine—breast cancer	1.57e-05	5.65e-05	CcSEcCtD
Ropinirole—Ill-defined disorder—Doxorubicin—breast cancer	1.56e-05	5.62e-05	CcSEcCtD
Ropinirole—Pruritus—Docetaxel—breast cancer	1.56e-05	5.61e-05	CcSEcCtD
Ropinirole—Nervous system disorder—Methotrexate—breast cancer	1.56e-05	5.6e-05	CcSEcCtD
Ropinirole—Anaemia—Doxorubicin—breast cancer	1.56e-05	5.6e-05	CcSEcCtD
Ropinirole—Thrombocytopenia—Methotrexate—breast cancer	1.55e-05	5.59e-05	CcSEcCtD
Ropinirole—Myalgia—Epirubicin—breast cancer	1.55e-05	5.58e-05	CcSEcCtD
Ropinirole—Arthralgia—Epirubicin—breast cancer	1.55e-05	5.58e-05	CcSEcCtD
Ropinirole—Chest pain—Epirubicin—breast cancer	1.55e-05	5.58e-05	CcSEcCtD
Ropinirole—Agitation—Doxorubicin—breast cancer	1.55e-05	5.57e-05	CcSEcCtD
Ropinirole—Anxiety—Epirubicin—breast cancer	1.54e-05	5.56e-05	CcSEcCtD
Ropinirole—Nausea—Paclitaxel—breast cancer	1.54e-05	5.55e-05	CcSEcCtD
Ropinirole—Skin disorder—Methotrexate—breast cancer	1.54e-05	5.55e-05	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.54e-05	5.54e-05	CcSEcCtD
Ropinirole—Hyperhidrosis—Methotrexate—breast cancer	1.53e-05	5.52e-05	CcSEcCtD
Ropinirole—Discomfort—Epirubicin—breast cancer	1.53e-05	5.51e-05	CcSEcCtD
Ropinirole—Asthenia—Capecitabine—breast cancer	1.53e-05	5.5e-05	CcSEcCtD
Ropinirole—Malaise—Doxorubicin—breast cancer	1.52e-05	5.46e-05	CcSEcCtD
Ropinirole—Dry mouth—Epirubicin—breast cancer	1.52e-05	5.45e-05	CcSEcCtD
Ropinirole—Vertigo—Doxorubicin—breast cancer	1.51e-05	5.44e-05	CcSEcCtD
Ropinirole—Anorexia—Methotrexate—breast cancer	1.51e-05	5.44e-05	CcSEcCtD
Ropinirole—Syncope—Doxorubicin—breast cancer	1.51e-05	5.43e-05	CcSEcCtD
Ropinirole—Pruritus—Capecitabine—breast cancer	1.51e-05	5.43e-05	CcSEcCtD
Ropinirole—Leukopenia—Doxorubicin—breast cancer	1.51e-05	5.42e-05	CcSEcCtD
Ropinirole—Diarrhoea—Docetaxel—breast cancer	1.51e-05	5.42e-05	CcSEcCtD
Ropinirole—Confusional state—Epirubicin—breast cancer	1.5e-05	5.39e-05	CcSEcCtD
Ropinirole—Palpitations—Doxorubicin—breast cancer	1.49e-05	5.36e-05	CcSEcCtD
Ropinirole—Oedema—Epirubicin—breast cancer	1.49e-05	5.35e-05	CcSEcCtD
Ropinirole—Hypotension—Methotrexate—breast cancer	1.48e-05	5.34e-05	CcSEcCtD
Ropinirole—Loss of consciousness—Doxorubicin—breast cancer	1.48e-05	5.33e-05	CcSEcCtD
Ropinirole—Infection—Epirubicin—breast cancer	1.48e-05	5.31e-05	CcSEcCtD
Ropinirole—Cough—Doxorubicin—breast cancer	1.47e-05	5.29e-05	CcSEcCtD
Ropinirole—Shock—Epirubicin—breast cancer	1.46e-05	5.26e-05	CcSEcCtD
Ropinirole—Convulsion—Doxorubicin—breast cancer	1.46e-05	5.25e-05	CcSEcCtD
Ropinirole—Diarrhoea—Capecitabine—breast cancer	1.46e-05	5.25e-05	CcSEcCtD
Ropinirole—Nervous system disorder—Epirubicin—breast cancer	1.46e-05	5.24e-05	CcSEcCtD
Ropinirole—Dizziness—Docetaxel—breast cancer	1.46e-05	5.24e-05	CcSEcCtD
Ropinirole—Thrombocytopenia—Epirubicin—breast cancer	1.45e-05	5.23e-05	CcSEcCtD
Ropinirole—Hypertension—Doxorubicin—breast cancer	1.45e-05	5.23e-05	CcSEcCtD
Ropinirole—Tachycardia—Epirubicin—breast cancer	1.45e-05	5.22e-05	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Methotrexate—breast cancer	1.45e-05	5.2e-05	CcSEcCtD
Ropinirole—Skin disorder—Epirubicin—breast cancer	1.44e-05	5.19e-05	CcSEcCtD
Ropinirole—Hyperhidrosis—Epirubicin—breast cancer	1.44e-05	5.17e-05	CcSEcCtD
Ropinirole—Insomnia—Methotrexate—breast cancer	1.44e-05	5.17e-05	CcSEcCtD
Ropinirole—Arthralgia—Doxorubicin—breast cancer	1.43e-05	5.16e-05	CcSEcCtD
Ropinirole—Chest pain—Doxorubicin—breast cancer	1.43e-05	5.16e-05	CcSEcCtD
Ropinirole—Myalgia—Doxorubicin—breast cancer	1.43e-05	5.16e-05	CcSEcCtD
Ropinirole—Anxiety—Doxorubicin—breast cancer	1.43e-05	5.14e-05	CcSEcCtD
Ropinirole—Paraesthesia—Methotrexate—breast cancer	1.43e-05	5.13e-05	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.42e-05	5.12e-05	CcSEcCtD
Ropinirole—Discomfort—Doxorubicin—breast cancer	1.42e-05	5.1e-05	CcSEcCtD
Ropinirole—Anorexia—Epirubicin—breast cancer	1.42e-05	5.1e-05	CcSEcCtD
Ropinirole—Dyspnoea—Methotrexate—breast cancer	1.42e-05	5.09e-05	CcSEcCtD
Ropinirole—Somnolence—Methotrexate—breast cancer	1.41e-05	5.08e-05	CcSEcCtD
Ropinirole—Dizziness—Capecitabine—breast cancer	1.41e-05	5.07e-05	CcSEcCtD
Ropinirole—Dry mouth—Doxorubicin—breast cancer	1.4e-05	5.05e-05	CcSEcCtD
Ropinirole—Vomiting—Docetaxel—breast cancer	1.4e-05	5.04e-05	CcSEcCtD
Ropinirole—Dyspepsia—Methotrexate—breast cancer	1.4e-05	5.03e-05	CcSEcCtD
Ropinirole—Rash—Docetaxel—breast cancer	1.39e-05	5e-05	CcSEcCtD
Ropinirole—Hypotension—Epirubicin—breast cancer	1.39e-05	4.99e-05	CcSEcCtD
Ropinirole—Dermatitis—Docetaxel—breast cancer	1.39e-05	4.99e-05	CcSEcCtD
Ropinirole—Confusional state—Doxorubicin—breast cancer	1.39e-05	4.99e-05	CcSEcCtD
Ropinirole—Decreased appetite—Methotrexate—breast cancer	1.38e-05	4.97e-05	CcSEcCtD
Ropinirole—Headache—Docetaxel—breast cancer	1.38e-05	4.96e-05	CcSEcCtD
Ropinirole—Oedema—Doxorubicin—breast cancer	1.37e-05	4.95e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Methotrexate—breast cancer	1.37e-05	4.93e-05	CcSEcCtD
Ropinirole—Fatigue—Methotrexate—breast cancer	1.37e-05	4.92e-05	CcSEcCtD
Ropinirole—Infection—Doxorubicin—breast cancer	1.37e-05	4.91e-05	CcSEcCtD
Ropinirole—Pain—Methotrexate—breast cancer	1.36e-05	4.88e-05	CcSEcCtD
Ropinirole—Vomiting—Capecitabine—breast cancer	1.36e-05	4.88e-05	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Epirubicin—breast cancer	1.35e-05	4.87e-05	CcSEcCtD
Ropinirole—Shock—Doxorubicin—breast cancer	1.35e-05	4.87e-05	CcSEcCtD
Ropinirole—Nervous system disorder—Doxorubicin—breast cancer	1.35e-05	4.85e-05	CcSEcCtD
Ropinirole—Thrombocytopenia—Doxorubicin—breast cancer	1.35e-05	4.84e-05	CcSEcCtD
Ropinirole—Rash—Capecitabine—breast cancer	1.34e-05	4.84e-05	CcSEcCtD
Ropinirole—Insomnia—Epirubicin—breast cancer	1.34e-05	4.83e-05	CcSEcCtD
Ropinirole—Dermatitis—Capecitabine—breast cancer	1.34e-05	4.83e-05	CcSEcCtD
Ropinirole—Tachycardia—Doxorubicin—breast cancer	1.34e-05	4.83e-05	CcSEcCtD
Ropinirole—Headache—Capecitabine—breast cancer	1.34e-05	4.81e-05	CcSEcCtD
Ropinirole—Skin disorder—Doxorubicin—breast cancer	1.34e-05	4.8e-05	CcSEcCtD
Ropinirole—Paraesthesia—Epirubicin—breast cancer	1.33e-05	4.8e-05	CcSEcCtD
Ropinirole—Hyperhidrosis—Doxorubicin—breast cancer	1.33e-05	4.78e-05	CcSEcCtD
Ropinirole—Dyspnoea—Epirubicin—breast cancer	1.32e-05	4.77e-05	CcSEcCtD
Ropinirole—Somnolence—Epirubicin—breast cancer	1.32e-05	4.75e-05	CcSEcCtD
Ropinirole—Anorexia—Doxorubicin—breast cancer	1.31e-05	4.71e-05	CcSEcCtD
Ropinirole—Nausea—Docetaxel—breast cancer	1.31e-05	4.71e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Methotrexate—breast cancer	1.31e-05	4.71e-05	CcSEcCtD
Ropinirole—Dyspepsia—Epirubicin—breast cancer	1.31e-05	4.71e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Methotrexate—breast cancer	1.3e-05	4.67e-05	CcSEcCtD
Ropinirole—Decreased appetite—Epirubicin—breast cancer	1.29e-05	4.65e-05	CcSEcCtD
Ropinirole—Hypotension—Doxorubicin—breast cancer	1.28e-05	4.62e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Epirubicin—breast cancer	1.28e-05	4.61e-05	CcSEcCtD
Ropinirole—Fatigue—Epirubicin—breast cancer	1.28e-05	4.61e-05	CcSEcCtD
Ropinirole—Constipation—Epirubicin—breast cancer	1.27e-05	4.57e-05	CcSEcCtD
Ropinirole—Pain—Epirubicin—breast cancer	1.27e-05	4.57e-05	CcSEcCtD
Ropinirole—Nausea—Capecitabine—breast cancer	1.27e-05	4.56e-05	CcSEcCtD
Ropinirole—Urticaria—Methotrexate—breast cancer	1.26e-05	4.54e-05	CcSEcCtD
Ropinirole—Abdominal pain—Methotrexate—breast cancer	1.26e-05	4.52e-05	CcSEcCtD
Ropinirole—Body temperature increased—Methotrexate—breast cancer	1.26e-05	4.52e-05	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.25e-05	4.51e-05	CcSEcCtD
Ropinirole—Insomnia—Doxorubicin—breast cancer	1.24e-05	4.47e-05	CcSEcCtD
Ropinirole—Paraesthesia—Doxorubicin—breast cancer	1.23e-05	4.44e-05	CcSEcCtD
Ropinirole—Dyspnoea—Doxorubicin—breast cancer	1.23e-05	4.41e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Epirubicin—breast cancer	1.22e-05	4.4e-05	CcSEcCtD
Ropinirole—Somnolence—Doxorubicin—breast cancer	1.22e-05	4.4e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Epirubicin—breast cancer	1.21e-05	4.37e-05	CcSEcCtD
Ropinirole—Dyspepsia—Doxorubicin—breast cancer	1.21e-05	4.35e-05	CcSEcCtD
Ropinirole—Decreased appetite—Doxorubicin—breast cancer	1.2e-05	4.3e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Doxorubicin—breast cancer	1.19e-05	4.27e-05	CcSEcCtD
Ropinirole—Fatigue—Doxorubicin—breast cancer	1.19e-05	4.26e-05	CcSEcCtD
Ropinirole—Urticaria—Epirubicin—breast cancer	1.18e-05	4.25e-05	CcSEcCtD
Ropinirole—Constipation—Doxorubicin—breast cancer	1.18e-05	4.23e-05	CcSEcCtD
Ropinirole—Pain—Doxorubicin—breast cancer	1.18e-05	4.23e-05	CcSEcCtD
Ropinirole—Abdominal pain—Epirubicin—breast cancer	1.17e-05	4.23e-05	CcSEcCtD
Ropinirole—Body temperature increased—Epirubicin—breast cancer	1.17e-05	4.23e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Methotrexate—breast cancer	1.17e-05	4.21e-05	CcSEcCtD
Ropinirole—Asthenia—Methotrexate—breast cancer	1.14e-05	4.1e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Doxorubicin—breast cancer	1.13e-05	4.08e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Doxorubicin—breast cancer	1.12e-05	4.04e-05	CcSEcCtD
Ropinirole—Pruritus—Methotrexate—breast cancer	1.12e-05	4.04e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Epirubicin—breast cancer	1.09e-05	3.94e-05	CcSEcCtD
Ropinirole—Urticaria—Doxorubicin—breast cancer	1.09e-05	3.93e-05	CcSEcCtD
Ropinirole—Body temperature increased—Doxorubicin—breast cancer	1.09e-05	3.91e-05	CcSEcCtD
Ropinirole—Abdominal pain—Doxorubicin—breast cancer	1.09e-05	3.91e-05	CcSEcCtD
Ropinirole—Diarrhoea—Methotrexate—breast cancer	1.09e-05	3.91e-05	CcSEcCtD
Ropinirole—Asthenia—Epirubicin—breast cancer	1.07e-05	3.84e-05	CcSEcCtD
Ropinirole—Pruritus—Epirubicin—breast cancer	1.05e-05	3.78e-05	CcSEcCtD
Ropinirole—Dizziness—Methotrexate—breast cancer	1.05e-05	3.78e-05	CcSEcCtD
Ropinirole—Diarrhoea—Epirubicin—breast cancer	1.02e-05	3.66e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Doxorubicin—breast cancer	1.01e-05	3.64e-05	CcSEcCtD
Ropinirole—Vomiting—Methotrexate—breast cancer	1.01e-05	3.63e-05	CcSEcCtD
Ropinirole—Rash—Methotrexate—breast cancer	1e-05	3.6e-05	CcSEcCtD
Ropinirole—Dermatitis—Methotrexate—breast cancer	1e-05	3.6e-05	CcSEcCtD
Ropinirole—Headache—Methotrexate—breast cancer	9.95e-06	3.58e-05	CcSEcCtD
Ropinirole—Asthenia—Doxorubicin—breast cancer	9.86e-06	3.55e-05	CcSEcCtD
Ropinirole—Dizziness—Epirubicin—breast cancer	9.83e-06	3.53e-05	CcSEcCtD
Ropinirole—Pruritus—Doxorubicin—breast cancer	9.73e-06	3.5e-05	CcSEcCtD
Ropinirole—Vomiting—Epirubicin—breast cancer	9.45e-06	3.4e-05	CcSEcCtD
Ropinirole—Nausea—Methotrexate—breast cancer	9.43e-06	3.39e-05	CcSEcCtD
Ropinirole—Diarrhoea—Doxorubicin—breast cancer	9.41e-06	3.38e-05	CcSEcCtD
Ropinirole—Rash—Epirubicin—breast cancer	9.37e-06	3.37e-05	CcSEcCtD
Ropinirole—Dermatitis—Epirubicin—breast cancer	9.36e-06	3.37e-05	CcSEcCtD
Ropinirole—Headache—Epirubicin—breast cancer	9.31e-06	3.35e-05	CcSEcCtD
Ropinirole—Dizziness—Doxorubicin—breast cancer	9.09e-06	3.27e-05	CcSEcCtD
Ropinirole—Nausea—Epirubicin—breast cancer	8.83e-06	3.18e-05	CcSEcCtD
Ropinirole—Vomiting—Doxorubicin—breast cancer	8.74e-06	3.14e-05	CcSEcCtD
Ropinirole—Rash—Doxorubicin—breast cancer	8.67e-06	3.12e-05	CcSEcCtD
Ropinirole—Dermatitis—Doxorubicin—breast cancer	8.66e-06	3.12e-05	CcSEcCtD
Ropinirole—Headache—Doxorubicin—breast cancer	8.61e-06	3.1e-05	CcSEcCtD
Ropinirole—Nausea—Doxorubicin—breast cancer	8.17e-06	2.94e-05	CcSEcCtD
Ropinirole—HTR2C—Signaling Pathways—PTEN—breast cancer	2.24e-06	2.19e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MAPK3—breast cancer	2.24e-06	2.19e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CTNNB1—breast cancer	2.24e-06	2.19e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ERCC2—breast cancer	2.23e-06	2.18e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—KRAS—breast cancer	2.23e-06	2.18e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NOS3—breast cancer	2.22e-06	2.17e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MAPK3—breast cancer	2.21e-06	2.16e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MAPK8—breast cancer	2.2e-06	2.15e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CXCL8—breast cancer	2.2e-06	2.15e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—AKT1—breast cancer	2.2e-06	2.15e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MMP9—breast cancer	2.19e-06	2.14e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MAPK8—breast cancer	2.19e-06	2.14e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—NCOA1—breast cancer	2.19e-06	2.14e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—AKT1—breast cancer	2.19e-06	2.14e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—HRAS—breast cancer	2.18e-06	2.14e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CDKN1A—breast cancer	2.18e-06	2.13e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PTEN—breast cancer	2.18e-06	2.13e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MYC—breast cancer	2.18e-06	2.13e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TGFB1—breast cancer	2.17e-06	2.12e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CXCL8—breast cancer	2.16e-06	2.11e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—SRC—breast cancer	2.16e-06	2.11e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—STK11—breast cancer	2.16e-06	2.11e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP19A1—breast cancer	2.16e-06	2.11e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—HRAS—breast cancer	2.15e-06	2.1e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CDKN1B—breast cancer	2.15e-06	2.1e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MYC—breast cancer	2.15e-06	2.1e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TGFB1—breast cancer	2.14e-06	2.09e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—KRAS—breast cancer	2.13e-06	2.08e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MAPK8—breast cancer	2.13e-06	2.08e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—PIK3CA—breast cancer	2.13e-06	2.08e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—EGFR—breast cancer	2.13e-06	2.08e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—AKT1—breast cancer	2.13e-06	2.08e-05	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—AKT1—breast cancer	2.12e-06	2.08e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTEN—breast cancer	2.12e-06	2.07e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	2.11e-06	2.07e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CDKN1B—breast cancer	2.11e-06	2.07e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—VEGFA—breast cancer	2.11e-06	2.06e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MDM2—breast cancer	2.1e-06	2.06e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CASP3—breast cancer	2.1e-06	2.06e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL2—breast cancer	2.1e-06	2.05e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—MTHFR—breast cancer	2.1e-06	2.05e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—EGFR—breast cancer	2.1e-06	2.05e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—RAF1—breast cancer	2.1e-06	2.05e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—IL6—breast cancer	2.09e-06	2.04e-05	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—AKT1—breast cancer	2.09e-06	2.04e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—RELA—breast cancer	2.09e-06	2.04e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—SRC—breast cancer	2.09e-06	2.04e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—STAT3—breast cancer	2.09e-06	2.04e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—PIK3CA—breast cancer	2.09e-06	2.04e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CG—breast cancer	2.08e-06	2.04e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—SRC—breast cancer	2.08e-06	2.03e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—ERBB2—breast cancer	2.08e-06	2.03e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CASP3—breast cancer	2.07e-06	2.02e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL2—breast cancer	2.07e-06	2.02e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TP53—breast cancer	2.06e-06	2.01e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—IL6—breast cancer	2.06e-06	2.01e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—PIK3CA—breast cancer	2.05e-06	2.01e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCND1—breast cancer	2.05e-06	2e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MTOR—breast cancer	2.05e-06	2e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	2.05e-06	2e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—JUN—breast cancer	2.04e-06	2e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—VEGFA—breast cancer	2.03e-06	1.99e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CTNNB1—breast cancer	2.03e-06	1.98e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—VEGFA—breast cancer	2.02e-06	1.98e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—SRC—breast cancer	2.02e-06	1.98e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TP53—breast cancer	2.02e-06	1.97e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCND1—breast cancer	2.02e-06	1.97e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—STAT3—breast cancer	2.01e-06	1.97e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—JUN—breast cancer	2.01e-06	1.97e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—KRAS—breast cancer	2.01e-06	1.97e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—COMT—breast cancer	2.01e-06	1.96e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—STAT3—breast cancer	2e-06	1.96e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CTNNB1—breast cancer	2e-06	1.95e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTP1—breast cancer	2e-06	1.95e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MAPK3—breast cancer	1.99e-06	1.95e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MMP9—breast cancer	1.99e-06	1.94e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TP53—breast cancer	1.99e-06	1.94e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—KRAS—breast cancer	1.98e-06	1.94e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CDKN1A—breast cancer	1.98e-06	1.94e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PTEN—breast cancer	1.98e-06	1.93e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—HRAS—breast cancer	1.97e-06	1.93e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—HMOX1—breast cancer	1.97e-06	1.92e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CXCL8—breast cancer	1.97e-06	1.92e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—VEGFA—breast cancer	1.97e-06	1.92e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ITPR1—breast cancer	1.96e-06	1.92e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—PIK3CA—breast cancer	1.96e-06	1.91e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MMP9—breast cancer	1.96e-06	1.91e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—HRAS—breast cancer	1.96e-06	1.91e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CDKN1A—breast cancer	1.95e-06	1.91e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—STAT3—breast cancer	1.95e-06	1.9e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PTEN—breast cancer	1.95e-06	1.9e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MYC—breast cancer	1.94e-06	1.89e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CAV1—breast cancer	1.94e-06	1.89e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MAPK8—breast cancer	1.93e-06	1.89e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TGFB1—breast cancer	1.93e-06	1.89e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—HRAS—breast cancer	1.93e-06	1.89e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—AKT1—breast cancer	1.93e-06	1.89e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MAPK3—breast cancer	1.92e-06	1.88e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	1.92e-06	1.88e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MAPK3—breast cancer	1.91e-06	1.87e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MAPK8—breast cancer	1.9e-06	1.86e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	1.9e-06	1.86e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—HRAS—breast cancer	1.9e-06	1.86e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—AKT1—breast cancer	1.9e-06	1.86e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—EGFR—breast cancer	1.9e-06	1.85e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TP53—breast cancer	1.89e-06	1.85e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ABCB1—breast cancer	1.89e-06	1.85e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—IL6—breast cancer	1.89e-06	1.84e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CASP3—breast cancer	1.88e-06	1.84e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL2—breast cancer	1.88e-06	1.84e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.87e-06	1.83e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MYC—breast cancer	1.87e-06	1.83e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TGFB1—breast cancer	1.87e-06	1.82e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MAPK3—breast cancer	1.86e-06	1.82e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MYC—breast cancer	1.86e-06	1.82e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TGFB1—breast cancer	1.86e-06	1.82e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—TYMS—breast cancer	1.86e-06	1.81e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.85e-06	1.81e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—PIK3CA—breast cancer	1.85e-06	1.81e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—IL6—breast cancer	1.85e-06	1.81e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PIK3CA—breast cancer	1.84e-06	1.8e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.83e-06	1.79e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—NCOR1—breast cancer	1.83e-06	1.79e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTM1—breast cancer	1.83e-06	1.79e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.83e-06	1.79e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—SRC—breast cancer	1.83e-06	1.79e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CD—breast cancer	1.83e-06	1.79e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—EGFR—breast cancer	1.83e-06	1.79e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—JUN—breast cancer	1.83e-06	1.79e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—PIK3CA—breast cancer	1.82e-06	1.78e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—EGFR—breast cancer	1.82e-06	1.78e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—IL6—breast cancer	1.82e-06	1.78e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.82e-06	1.78e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—HRAS—breast cancer	1.81e-06	1.77e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MYC—breast cancer	1.81e-06	1.77e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ALB—breast cancer	1.81e-06	1.77e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TGFB1—breast cancer	1.81e-06	1.77e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—SRC—breast cancer	1.8e-06	1.76e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—KRAS—breast cancer	1.79e-06	1.75e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TP53—breast cancer	1.79e-06	1.75e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—VEGFA—breast cancer	1.79e-06	1.75e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MMP9—breast cancer	1.78e-06	1.74e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	1.77e-06	1.73e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—EGFR—breast cancer	1.77e-06	1.73e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PTEN—breast cancer	1.77e-06	1.73e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—STAT3—breast cancer	1.77e-06	1.73e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CG—breast cancer	1.76e-06	1.73e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TP53—breast cancer	1.76e-06	1.72e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—VEGFA—breast cancer	1.76e-06	1.72e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GPX1—breast cancer	1.76e-06	1.72e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—AKT1—breast cancer	1.74e-06	1.7e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—STAT3—breast cancer	1.74e-06	1.7e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP1A1—breast cancer	1.74e-06	1.7e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—IL6—breast cancer	1.73e-06	1.7e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MAPK8—breast cancer	1.73e-06	1.69e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—NOS3—breast cancer	1.73e-06	1.69e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—KRAS—breast cancer	1.73e-06	1.69e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—AKT1—breast cancer	1.73e-06	1.69e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ERCC2—breast cancer	1.72e-06	1.69e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—KRAS—breast cancer	1.72e-06	1.68e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—HRAS—breast cancer	1.71e-06	1.67e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—AKT1—breast cancer	1.7e-06	1.67e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MAPK3—breast cancer	1.69e-06	1.65e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—HRAS—breast cancer	1.69e-06	1.65e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—AKT1—breast cancer	1.68e-06	1.64e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—KRAS—breast cancer	1.67e-06	1.64e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MAPK3—breast cancer	1.66e-06	1.62e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	1.65e-06	1.61e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MYC—breast cancer	1.64e-06	1.61e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SRC—breast cancer	1.64e-06	1.6e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TGFB1—breast cancer	1.64e-06	1.6e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—IL6—breast cancer	1.64e-06	1.6e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—MTHFR—breast cancer	1.62e-06	1.58e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MYC—breast cancer	1.62e-06	1.58e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—IL6—breast cancer	1.61e-06	1.58e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TGFB1—breast cancer	1.61e-06	1.58e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—EGFR—breast cancer	1.61e-06	1.57e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—AKT1—breast cancer	1.6e-06	1.56e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—VEGFA—breast cancer	1.6e-06	1.56e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CB—breast cancer	1.6e-06	1.56e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TP53—breast cancer	1.59e-06	1.56e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PIK3CA—breast cancer	1.59e-06	1.55e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—STAT3—breast cancer	1.58e-06	1.55e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTGS2—breast cancer	1.58e-06	1.55e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—EGFR—breast cancer	1.58e-06	1.55e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PIK3CA—breast cancer	1.58e-06	1.54e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CD—breast cancer	1.55e-06	1.52e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PIK3CA—breast cancer	1.54e-06	1.5e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TP53—breast cancer	1.54e-06	1.5e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ALB—breast cancer	1.53e-06	1.5e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TP53—breast cancer	1.53e-06	1.49e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—HRAS—breast cancer	1.52e-06	1.49e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—KRAS—breast cancer	1.52e-06	1.48e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MAPK3—breast cancer	1.51e-06	1.48e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—AKT1—breast cancer	1.51e-06	1.48e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—AKT1—breast cancer	1.5e-06	1.47e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CAV1—breast cancer	1.5e-06	1.46e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—KRAS—breast cancer	1.49e-06	1.46e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PIK3CA—breast cancer	1.49e-06	1.46e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—AKT1—breast cancer	1.49e-06	1.46e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TP53—breast cancer	1.49e-06	1.45e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MYC—breast cancer	1.47e-06	1.44e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—HRAS—breast cancer	1.47e-06	1.44e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TGFB1—breast cancer	1.47e-06	1.43e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—NOS3—breast cancer	1.46e-06	1.43e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—HRAS—breast cancer	1.46e-06	1.43e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL6—breast cancer	1.46e-06	1.42e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EGFR—breast cancer	1.44e-06	1.41e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—HRAS—breast cancer	1.42e-06	1.39e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL6—breast cancer	1.41e-06	1.38e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL6—breast cancer	1.4e-06	1.37e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PIK3CA—breast cancer	1.39e-06	1.36e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTEN—breast cancer	1.38e-06	1.35e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PIK3CA—breast cancer	1.37e-06	1.34e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CG—breast cancer	1.36e-06	1.33e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL6—breast cancer	1.36e-06	1.33e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—KRAS—breast cancer	1.36e-06	1.33e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CB—breast cancer	1.35e-06	1.32e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TP53—breast cancer	1.35e-06	1.32e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—AKT1—breast cancer	1.34e-06	1.31e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTGS2—breast cancer	1.34e-06	1.31e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TP53—breast cancer	1.33e-06	1.3e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—AKT1—breast cancer	1.3e-06	1.27e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—AKT1—breast cancer	1.29e-06	1.26e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—HRAS—breast cancer	1.29e-06	1.26e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—HRAS—breast cancer	1.27e-06	1.24e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—AKT1—breast cancer	1.26e-06	1.23e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	1.25e-06	1.22e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL6—breast cancer	1.23e-06	1.21e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—AKT1—breast cancer	1.22e-06	1.19e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL6—breast cancer	1.22e-06	1.19e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TP53—breast cancer	1.21e-06	1.18e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CD—breast cancer	1.2e-06	1.17e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ALB—breast cancer	1.18e-06	1.16e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTEN—breast cancer	1.17e-06	1.14e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—HRAS—breast cancer	1.16e-06	1.13e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AKT1—breast cancer	1.14e-06	1.11e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—NOS3—breast cancer	1.13e-06	1.11e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AKT1—breast cancer	1.12e-06	1.1e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL6—breast cancer	1.11e-06	1.08e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CB—breast cancer	1.04e-06	1.02e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTGS2—breast cancer	1.03e-06	1.01e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AKT1—breast cancer	1.02e-06	9.97e-06	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CA—breast cancer	9.73e-07	9.51e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTEN—breast cancer	9.02e-07	8.81e-06	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CA—breast cancer	8.24e-07	8.06e-06	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—AKT1—breast cancer	7.95e-07	7.77e-06	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—AKT1—breast cancer	6.73e-07	6.58e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CA—breast cancer	6.36e-07	6.22e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—AKT1—breast cancer	5.2e-07	5.08e-06	CbGpPWpGaD
